Picture of IRIDEX logo

IRIX IRIDEX Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for IRIDEX, fiscal year end - December 30th, USD millions except per share, conversion factor applied.

2019
December 28th
2021
January 2nd
2022
December 31st
2022
January 1st
2023
December 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-8.81-6.33-7.55-5.22-9.57
Depreciation
Non-Cash Items1.781.321.81-0.8291.65
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.561.27-4.2613.50.077
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-7.91-3.24-9.528.22-6.75
Capital Expenditures-0.128-0.097-0.286-0.213-0.109
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.3810.0040-5.34
Acquisition of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.509-0.093-0.286-5.56-0.109
Financing Cash Flow Items-0.156-0.03-0.094-0.629-0.087
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.1562.47-0.0739.47-0.005
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-8.54-1.03-9.9312.2-6.89